The decreased Proteobacteria levels in MI patients may disrupt arginine metabolism, leading to altered mTOR pathway activity, which could contribute to impaired immune regulation and metabolic dysfunction associated with MI (Khan et al., 2025). The gene discussed is MTOR; the disease is myocardial infarction.